Drug Shortage Report for OCTREOTIDE ACETATE OMEGA
| Report ID | 190174 |
| Drug Identification Number | 02248642 |
| Brand name | OCTREOTIDE ACETATE OMEGA |
| Common or Proper name | Octreotide Acetate Injection |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | OCTREOTIDE |
| Strength(s) | 200MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 1 x 5 mL vial / fiole |
| ATC code | H01CB |
| ATC description | HYPOTHALAMIC HORMONES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-04-21 |
| Estimated end date | 2023-04-28 |
| Actual end date | 2023-04-25 |
| Shortage status | Resolved |
| Updated date | 2023-04-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-04-26 | English | Compare |
| v5 | 2023-04-25 | French | Compare |
| v4 | 2023-04-25 | English | Compare |
| v3 | 2023-04-22 | English | Compare |
| v2 | 2023-04-21 | French | Compare |
| v1 | 2023-04-21 | English | Compare |
Showing 1 to 6 of 6